These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6625590)

  • 41. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of seasonal allergic rhinitis using homeopathic preparation of common allergens in the southwest region of the US: a randomized, controlled clinical trial.
    Kim LS; Riedlinger JE; Baldwin CM; Hilli L; Khalsa SV; Messer SA; Waters RF
    Ann Pharmacother; 2005 Apr; 39(4):617-24. PubMed ID: 15741420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sublingual specific immunotherapy for rhinoconjunctivitis caused by grass pollens].
    Sabbah A; Lesellin J; Hassoun S; Sicard H; André C
    Allerg Immunol (Paris); 1993 Jun; 25(6):241-7. PubMed ID: 8357473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients.
    Troise C; Bignardi D; Modena P; Pissacroia C; Di Berardino F
    Allerg Immunol (Paris); 2000 Jun; 32(6):246-9. PubMed ID: 10971859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of the therapeutic results obtained with alum-pyridine pollen extracts and aqeuous extracts].
    Centanni G
    Folia Allergol (Roma); 1970; 17(3):309-26. PubMed ID: 5517222
    [No Abstract]   [Full Text] [Related]  

  • 46. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A
    MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
    [No Abstract]   [Full Text] [Related]  

  • 47. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CLINICAL AND IMMUNOLOGIC EVALUATION OF A PURIFIED FRACTION OF RAGWEED POLLEN (DELTA). A DOUBLE-BLIND STUDY.
    ARBESMAN CE; REISMAN RE; KUNZ ML
    J Allergy; 1965; 36():29-38. PubMed ID: 14320908
    [No Abstract]   [Full Text] [Related]  

  • 49. Regulatory control and standardization of allergenic extracts.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):177-220. PubMed ID: 3196018
    [No Abstract]   [Full Text] [Related]  

  • 50. [Specific desensitization of pollinosis using aqueous antigen extracts].
    Wozniak KD; Gutschmidt E; Stadie W
    Z Gesamte Inn Med; 1973 Jun; 28(12):375-8. PubMed ID: 4729268
    [No Abstract]   [Full Text] [Related]  

  • 51. Standardization of allergen extracts.
    Matthiesen F
    Z Hautkr; 1988; 63 Suppl 4():52-4. PubMed ID: 3252626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pollen challenge study of a phototherapy device for reducing the symptoms of hay fever.
    Emberlin JC; Lewis RA
    Curr Med Res Opin; 2009 Jul; 25(7):1635-44. PubMed ID: 19476405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory control and standardization of allergenic extracts. Leading motive: thesis and antithesis.
    Göing H
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):7-11. PubMed ID: 6625587
    [No Abstract]   [Full Text] [Related]  

  • 54. Timothy pollen oral lyophilisate (standardised allergenic extract): new drug. Hay fever: 4 months' treatment for 4 days' relief?
    Prescrire Int; 2008 Oct; 17(97):196. PubMed ID: 19536935
    [No Abstract]   [Full Text] [Related]  

  • 55. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
    Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
    Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    Williams A; Henzgen M; Rajakulasingam K
    Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blocking antibodies in allergic rhinitis.
    Hlasivcová V
    Acta Allergol; 1969 Sep; 24(3):194-201. PubMed ID: 5395877
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined effect of the allergen and thymus extract (TFX) in the desensitization of patients with hay fever].
    Turowski G; Dynowska D; Sanokowska E; Kotlinowska T
    Pol Tyg Lek; 1987 Jun; 42(24):745-6. PubMed ID: 3671177
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pollinosis].
    Drira I; Chebbi ML
    Tunis Med; 1996 Nov; 74(11):471-6. PubMed ID: 9506109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.